Related Experiment Video
Updated: Aug 5, 2026
09:04
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
The Microglial NLRP3 Inflammasome in Multiple Sclerosis: Bridging Innate Immunity, Chronic Inflammation, and IFN-β
Prathyusha Koyya1, Hemasundar Alavilli1, Santhi Latha Pandrangi1
1Department of Life Sciences, GITAM School of Science, Gandhi Institute of Technology and Management (Deemed to be University), Visakhapatnam, India.
Immunological Investigations
|July 27, 2026
Summary
The NLRP3 inflammasome plays a key role in multiple sclerosis (MS) pathogenesis and microglial activation. Understanding its interaction with interferon-beta (IFN-β) may improve personalized MS treatments.
Area of Science:
- Neuroimmunology
- Molecular Biology
Background:
- Multiple sclerosis (MS) is a chronic CNS neurodegenerative and demyelinating disease characterized by inflammation.
- Interferon-beta (IFN-β) is a primary treatment for relapsing-remitting MS (RRMS), but patient responses vary, necessitating deeper understanding of immunopathology.
Purpose of the Study:
- To review the role of the NLRP3 inflammasome in MS pathogenesis.
- To explore the connection between NLRP3 inflammasome activity, microglial activation, and IFN-β response in MS.
Main Methods:
- Literature review of existing data on NLRP3 inflammasome, microglia, and IFN-β in MS.
- Analysis of immunopathological mechanisms in MS.
Main Results:
- Aberrant microglial NLRP3 inflammasome activity is linked to demyelination and axonal degeneration in MS.
- IFN-β may inhibit inflammasome activity, suggesting a mechanistic link between NLRP3 signaling and treatment response.
Conclusions:
- The NLRP3 inflammasome is a significant contributor to MS pathogenesis and microglial activation.
- Targeting the NLRP3 inflammasome pathway could offer novel strategies for personalized MS treatment approaches.
Related Concept Videos
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:26Acute Inflammation I: Inflammatory Response
Acute inflammation is a rapid, short-lived physiological response to tissue injury or infection, designed to eliminate harmful agents and initiate repair. This tightly regulated process typically lasts from minutes to several days and is triggered by factors such as microbial invasion, physical trauma, or chemical injury.Recognition and Mediator ReleaseThe inflammatory response begins when resident immune cells—such as mast cells, macrophages, and dendritic cells—detect damage-associated...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...